Stopping GLP-1 Receptor Agonists… Why And How To Plan An “Exit Strategy” For Your Patients
Read the full article here
Read the full article here
In conclusion, discontinuing semaglutide or tirzepatide therapy for weight reduction poses unique challenges that require careful consideration and management. By comprehensively understanding the potential effects and implementing strategies such as the use of Amarasate® to support patients through this transition, practitioners can optimize patient outcomes and promote long-term success in weight management.
The Centers for Medicare & Medicaid Services is continually working to mitigate unnecessary expenditures, particularly in post-acute care (PAC). Medicare reimburses for orthopaedic surgeon services…
This cross-sectional study investigates PAH incidence for historically marginalized NH residents with severe cognitive impairment compared with non-Hispanic White residents.
Echocardiography is a fundamental component of pediatric cardiology, and appropriate indications have been established for its use in the setting of suspected, congenital, or acquired…
Advances in biomedical research require a robust physician scientist workforce. Despite being equally successful at securing early career awards from the NIH as men, women…
Prof Tom Cameron is working with oystermen in Essex to restore the number of shellfish in the waters.
The last time you went to the emergency room or to a doctor’s office, were you surprised to be seen by a Nurse Practitioner or…
Edited by Alexandra Lansky, MD, Yale University, New Haven, CT, USA Even if the Fontan operation is the surgical treatment of choice in patients with…
KEY POINTS In 2022, The College of Family Physicians of Canada (CFPC) published its final report of the Outcomes of Training Project, including the recommendation…
The immune checkpoint inhibitor anti-PD-1, commonly used in cancer immunotherapy, has not been successful as a monotherapy for the highly aggressive brain cancer glioblastoma. However,…
Besides many other mutations in known cancer driver genes, mantle cell lymphoma (MCL) is characterized by recurrent genetic alterations of important regulators of the phosphoinositol-3-kinase…